CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Microbot Medical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Microbot Medical Inc
175 Derby St Bld 27
Phone: (781) 875-3605p:781 875-3605 HINGHAM, MA  02043  United States Ticker: MBOTMBOT
Business Summary
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer HarelGadot 52 12/5/2016 11/28/2016
Chief Financial Officer RachelVaknin 46 4/1/2022 1/1/2022
Chief Technology Officer, General Manager of Microbot Israel SimonSharon 64 4/7/2021 4/5/2018
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Stem Cell Sciences Plc. 7707 Gateway Blvd. Suite 140 Newark CA United States

Business Names
Business Name
C&RD Israel Ltd.
MBOT
Microbot Medical Ltd.
STEM

General Information
Number of Employees: 21 (As of 3/24/2025)
Outstanding Shares: 36,377,812 (As of 5/12/2025)
Shareholders: 117
Stock Exchange: NASD
Federal Tax Id: 943078125
Fax Number: (302) 655-5049
Email Address: offadm@stemcell.net


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 23, 2025